z-logo
open-access-imgOpen Access
Jujuboside B Reverse CUMS-Promoted Tumor Progression via Blocking PI3K/Akt and MAPK/ERK and Dephosphorylating CREB Signaling
Author(s) -
Zhen Yang,
Weijia Cai,
Yitian Chen,
Zhijun Guo,
Zhijun Xiao,
Ting Zhou,
Yuanchi Cheng,
Feng Xu
Publication year - 2022
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 83
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2022/5211368
Subject(s) - protein kinase b , mapk/erk pathway , pi3k/akt/mtor pathway , creb , apoptosis , chemistry , tumor progression , endocrinology , tumor necrosis factor alpha , proinflammatory cytokine , cancer research , medicine , signal transduction , cancer , pharmacology , inflammation , biochemistry , transcription factor , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom